Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Cash from Operations (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of Cash from Operations data on record, last reported at 96109.0 in Q3 2025.

  • On a quarterly basis, Cash from Operations fell 78.16% to 96109.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 716999.0, a N/A change, with the full-year FY2024 number at 672289.0, changed N/A from a year prior.
  • Cash from Operations reached 96109.0 in Q3 2025 per AFJK's latest filing, up from 201750.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AFJK hit a ceiling of 53946.0 in Q3 2024 and a floor of 256242.0 in Q2 2024.